NCT03122886View on ClinicalTrials.gov

Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

July 14, 2017

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2019

Conditions
Advanced Malignant Neoplasm
Interventions
DIETARY_SUPPLEMENT

Fat Emulsion

Given IV

OTHER

Placebo

Given IV

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT03122886 - Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin | Biotech Hunter | Biotech Hunter